Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-26-108289
Filing Date
2026-03-16
Accepted
2026-03-16 16:00:02
Documents
2
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 9021
2 EX-99.1 ck0001540159-ex99_1.pdf EX-99.1 252821
  Complete submission text file 0001193125-26-108289.txt   359244
Mailing Address 51 ASTOR PLACE, 10TH FLOOR NEW YORK NY 10003
Business Address 51 ASTOR PLACE, 10TH FLOOR NEW YORK NY 10003 646-205-5300
PERCEPTIVE ADVISORS LLC (Filed by) CIK: 0001224962 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 100 SPY COURT MARKHAM Ontario, Canada
Business Address 100 SPY COURT MARKHAM Ontario, Canada (905) 475-1234
Edesa Biotech, Inc. (Subject) CIK: 0001540159 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: SCHEDULE 13G | Act: 34 | File No.: 005-87615 | Film No.: 26756457
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)